13F Holdings
中文EN

INSP Inspire Medical Systems, Inc.

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 1609550 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-0.2%
TTM net income YoY126.0%
TTM EPS YoY129.5%
Revenue 3-yr CAGR15.6%
Net income 3-yr CAGR—

Margins

Gross margin86.2%
Operating margin1.8%
Net margin11.4%
FCF margin11.1%
EBITDA margin3.9%

Returns

ROE13.5%
ROA11.4%
ROIC (approx.)2.6%
Asset turnover1.00x

Leverage & solvency

Liabilities / assets13.2%
Debt / equity0.00x
Current ratio6.45x
Interest coverage—

Cash quality & payout

Operating cash flow / net income1.34x
Accruals ratio-3.9%
Payout ratio—
Capex / revenue4.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$911.98M$802.80M$624.80M$407.86M$233.39M
Cost of revenue$133.22M$122.99M$96.58M$66.11M$33.28M
Gross profit$778.76M$679.82M$528.22M$341.74M$200.12M
R&D expense$103.17M$114.13M$116.54M$68.64M$37.35M
SG&A expense$624.64M$529.61M$451.96M$320.69M$202.62M
Operating income$50.95M$36.08M-$40.27M-$47.59M-$39.85M
Interest expense$137,000$22,000$0$1.68M$2.13M
Pretax income$65.70M$58.45M-$19.91M-$44.27M-$41.97M
Income tax-$79.72M$4.94M$1.25M$613,000$72,000
Net income$145.42M$53.51M-$21.15M-$44.88M-$42.04M
EBITDA$64.91M$42.63M-$37.42M-$45.73M-$38.63M
EPS (basic)4.951.80-0.72-1.60-1.54
EPS (diluted)4.891.75-0.72-1.60-1.54
Weighted avg. shares (diluted)29.76M30.54M29.30M28.07M27.26M
Balance sheet
Cash & equivalents$104.81M$150.15M$185.54M$441.59M$214.47M
Short-term investments$203.46M$295.40M$274.84M$9.82M$0
Receivables$119.69M$93.07M$89.88M$61.23M$34.18M
Inventory$145.29M$80.12M$33.88M$11.89M$17.23M
Current assets$583.65M$630.81M$593.74M$530.03M$268.54M
PP&E, net$97.87M$71.92M$39.98M$17.25M$8.49M
Total assets$907.32M$808.38M$676.81M$564.88M$295.08M
Current liabilities$96.06M$88.50M$78.11M$61.19M$41.31M
Long-term debt————$24.50M
Total debt————$24.50M
Total liabilities$126.16M$118.69M$104.30M$68.87M$66.04M
Shareholders' equity$781.16M$689.70M$572.51M$496.01M$229.05M
Net debt————-$189.97M
Shares outstanding28.58M29.74M29.56M29.01M27.42M
Cash flow statement
Operating cash flow$116.98M$130.25M$24.65M$11.57M-$20.12M
Capital expenditure$38.50M$39.12M$23.63M$9.10M$4.67M
Free cash flow$78.48M$91.12M$1.02M$2.47M-$24.79M
Investing cash flow$21.45M-$113.12M-$294.82M-$19.60M$29.14M
Financing cash flow-$183.45M-$52.39M$13.95M$235.08M$14.95M
Depreciation & amortization$13.96M$6.55M$2.85M$1.86M$1.22M
Stock-based compensation$130.26M$116.01M$82.47M$51.97M$26.18M
Share buybacks$175.02M$0$0$0—

Free plan shows the latest 5 periods; Pro shows all 10 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.